drugset / Trial / NCT00003580

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

NCT00003580

Phase 2 Completed University of Tennessee
Supportive care

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Drugs such as amifostine may protect normal cells from the side effects of chemotherapy and radiation therapy. PURPOSE: Phase II trial to study the effectiveness of amifostine in treating side effects of treatment in patients receiving radiation therapy and cisplatin for advanced head and neck cancer.

Timeline

Start
1998-06
Primary completion
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject amifostine Unknown Intravenous
Background Cisplatin Other / unclassified Other